Objective To explore the effect of quality control management applied to blood sam-ples tested. Methods Data of the blood samples in 280 patients from December 2012 to Decem-ber 2013 in our hospital was randomly selected, all collected in two physical groups. The quality control interventions in non-hemolytic samples as study groups, hemolytic samples collected by non-standard blood as the control group, and the results of related records were analyzed. Results AST and ALT in study group were lower than the control group, the difference was significant (P<0.05);r-GT indicators in research group were significantly different than the control group (P<0.05); And positive rate of hepatitis B 4h was 0.36%, less than 0h 2.86%(P<0.05); Positive rate of HCV disease 4h was 0, less than 0h 1.07% (P<0.05); While positive rate of syphilis disease 6h was 0, and less than 0h 0.71% (P<0.05); Positive rate of AIDS was 0, less than 0h was 0.36%, the difference was statistically significant (P<0.05). Conclusion Quality control manage-ment interventions of biochemical subjects can effectively improve the accuracy of the blood tests, with some clinical applications and research value.%目的：探究质量控制管理应用于血液标本检验的效果观察。方法随机选自2012年12月～2013年12月在本院进行血液检验体检者280例，将所有体检者的血液样本采集两份，予以质量控制干预非溶血样本作研究组，不规范血液采集的溶血样本作对照组，记录相关结果并予以分析。结果研究组AST和 ALT比对照组低，差异明显（P＜0.05）；研究组r-GT 指标比对照组高，差异明显（P＜0.05）；且乙肝4h 的阳性检出率0.36%，比0h 的2.86%少（P＜0.05）；丙肝疾病4h的阳性检出率0，比0h的1.07%少（P＜0.05）；同时梅毒疾病6h的阳性检出率0，比0h的0.71%少（P＜0.05）；艾滋病2h阳性检出率0，比0h的0.36%少，比较差异明显，具统计学上的意义（P＜0.05）。结论血液生化受检者规范化的质量控制管理干预能有效提升血液检验准确性，具有一定临床应用和研究价值。
展开▼
